Ara
Toplam kayıt 31, listelenen: 21-30
Atorvastatin Causes Regression of Endometriotic Implants in a Rat Model
(Elsevier Sci Ltd, 2010)
Endometriotic implants were induced surgically in female Wistar albino rats, which were randomly divided into three groups. The rats in group I (n = 10) and group II (n = 9) were given 2.5 mg/kg/day intraperitoneal and ...
Ovarian And Adipose Tissue Dysfunction In Polycystic Ovary Syndrome: Report Of The 4Th Special Scientific Meeting Of The Androgen Excess And Pcos Society
(Elsevier Science Inc, 2010)
Significant advances have been made in our understanding of ovarian dysfunction in polycystic ovary syndrome (PCOS), and alterations in adipose tissue function are likely to play an important role in its pathophysiology. ...
The Effect of Serum and Follicular Fluid Amyloid-Associated Protein Levels on in Vitro Fertilization Outcome in Patients with Polycystic Ovary Syndrome
(Springer/Plenum Publishers, 2015)
In this study, we aimed to investigate serum and follicular fluid amyloid A protein levels in non-obese non-hyperandrogenic patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) and IVF ...
Association Between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients
(Wiley, 2013)
The aim of this study was to evaluate the association of bone mineral density (BMD) at the time of diagnosis with clinical-pathologic findings in patients with operable postmenopausal breast cancer. One hundred and fifty-eight ...
Metabolic Syndrome, Hypertension, And Hyperlipidemia In Mothers, Fathers, Sisters, And Brothers Of Women With Polycystic Ovary Syndrome: A Systematic Review And Meta-Analysis
(Elsevier Science Inc, 2018)
Objective: To provide an evidence-based assessment of metabolic syndrome, hypertension, and hyperlipidemia in first-degree relatives of women with polycystic ovary syndrome (PCOS). Design: Systematic review and meta-analysis. ...
Consensus On Women'S Health Aspects Of Polycystic Ovary Syndrome (Pcos)
(Oxford Univ Press, 2012)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females with a high prevalence. The etiology of this heterogeneous condition remains obscure and its phenotype expression varies. Two, widely cited, ...
Effect of An Oral Contraceptive on Emotional Distress, Anxiety and Depression of Women With Polycystic Ovary Syndrome: A Prospective Study
(Oxford Univ Press, 2012)
We aimed to determine the impact of an oral contraceptive (OC) treatment on health-related quality of life (HRQOL), depressive and anxiety symptoms in polycystic ovary syndrome (PCOS). OC therapy in PCOS improves hirsutism ...
Prevalence, Phenotype and Cardiometabolic Risk of Polycystic Ovary Syndrome Under Different Diagnostic Criteria
(Oxford Univ Press, 2012)
What is the prevalence, phenotype and metabolic features of polycystic ovary syndrome (PCOS) in the same population according to three different diagnostic criteria? The prevalence of PCOS under National Institutes of ...
Visfatin And Retinol-Binding Protein 4 Concentrations In Lean, Glucose-Tolerant Women With Pcos
(Elsevier Sci Ltd, 2010)
Since insulin resistance is accepted to be a common feature of polycystic ovary syndrome (PCOS), the exact molecular mechanism(s) involved in glucose and lipid metabolism have been under investigation in the syndrome. ...
Visually Scoring Hirsutism
(Oxford Univ Press, 2010)
Hirsutism is the presence of excess body or facial terminal (coarse) hair growth in females in a male-like pattern, affects 5-15% of women, and is an important sign of underlying androgen excess. Different methods are ...